Novo Nordisk shares 2030 business plan in London

Novo Nordisk held its 2026 Capital Markets Day, a day-long briefing for investors, in London on 21 September 2026, the company said. Running 09:00-15:30 BST (London time), senior bosses laid out business strategy, medicines in development, how the company runs, and recent results, plus a refreshed company plan and goals for 2030.